Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

The Big Data Institute (BDI) has recently announced new research alliances with Novartis and Sensyne Health.

Bdi 1

The Big Data Institute (BDI) have recently announced two new research alliances:

  1. A five-year collaboration with Novartis to establish a world-leading research alliance that will improve drug development by making it more efficient and more targeted. Using artificial intelligence (AI) and advanced analytics, the partners expect to transform how ultra large and multiple datasets are analysed, combined and interpreted to identify early predictors of patient responses to treatments for inflammatory diseases, such as multiple sclerosis (MS) and psoriasis. Read more
  2. A three year alliance with Sensyne Health to advance the analysis and interpretation of NHS datasets. These datasets, in chronic kidney disease and cardiovascular disease, will be analysed using clinical artificial intelligence that will be used to improve care and accelerate the discovery and development of new medicines. Read more